2019 Michelson Prize Winners Announced

June 14, 2019
Pharmaceutical Technology Editors

Pharmaceutical Technology's In the Lab eNewsletter

In the Lab eNewsletter, Pharmaceutical Technology\'s In the Lab eNewsletter-07-02-2019, Volume 14, Issue 7

The Michelson Medical Research Foundation and the Human Vaccines Project have awarded three young scientists $150,000 for their novel approaches toward human immune system research.

On June 13, 2019, the Michelson Medical Research Foundation and the Human Vaccines Project, a public-private initiative that aims to accelerate human vaccine development, announced the winners of the 2019 Michelson Prizes. The three young scientists will each receive $150,000 for their novel approaches toward deciphering how the human immune system fights disease.

“The Michelson Prizes were established to enable early career scientists to pursue disruptive, high-risk, and innovative ideas that have the potential for high impact across disease areas and that likely would not be funded by traditional grant mechanisms,” said Gary Michelson, MD, founder of the Michelson Medical Research Foundation, in a press release. “This year’s winners truly represent the next generation of innovative scientists, building the toolkit by which humanity can pursue longer and healthier lives.”

This year’s winners include:

  • Murad Mamedov, University of California, San Francisco (UCSF), for his project titled “Mapping γδ T Cell Receptor Ligands”. Mamedov is using gene-editing technologies to create a new platform for understanding an important set of immune cells that may provide the keys to the diagnosis, prevention, and treatment of infectious and non-communicable diseases such as cancer.

  • Kamal Mandal, UCSF, for his project titled “’Structural Surfaceomics’: An Approach to Identify Cancer-Specific Cell Surface Protein Conformations for Immunotherapeutic Targeting”. Mandal is developing new technologies that identify the shape of proteins that could provide new targets for cancer immunotherapy, with potential applications to other diseases.

  • Avinash Das Sahu, Dana-Farber Cancer Institute and Massachusetts General Hospital, for his project titled “Identification of Cancer Drugs that Boost Immunotherapy Response”. Sahu is building novel artificial-intelligence (AI) deep-learning frameworks to develop new therapeutic strategies for cancer immunotherapy, with potential applications in human immunology.

“We are seeing a paradigm shift in human immunology, as the convergence of computational, AI, and machine learning tools combine with advances in genomics and immunobiology to offer an unprecedented opportunity for innovation,” says Wayne Koff, CEO of the Human Vaccines Project, in a press release. “This year’s Michelson Prize winners reflect this shift, bringing ideas that could truly transform how we fight major global diseases.”

Now in its second year, the Michelson Prizes recognize researchers under the age of 35 who are conducting research on human immunology using technological advances from genomics, computational biology, and machine learning to work to transform the future of human health. This year’s winners were selected from a global competition that included more than 150 applications spanning 35 countries. The prize recipients will receive their awards on June 18, 2019, at the University of California, Los Angeles, CA, where they will also participate in a Human Vaccines Project sponsored symposium titled “The Future of Vaccine and Immunotherapy Development: Towards an Artificial Intelligence Driven Model of the Human Immune System”.

Applications for the 2020 Michelson Prizes for Human Immunology and Vaccine Research will open on Sept. 9, 2019. Click here to learn more.

Source: Human Vaccines Project